ChemoMetec A/S financials at a glance

+ Portfolio

The revenue of ChemoMetec A/S is reported as 0.44227 billion Kroner in the fiscal year 2023. The earnings were 10.27 Kroner per share in 2023, which was 12.12 higher than 2022. And about 0.13297 billion Kroner are reported as free cash flow in the financials of ChemoMetec A/S 2023. Dividends of 0 Kroner per share were paid to shareholders of ChemoMetec A/S stock CPSE:CHEMM in fiscal 2023.

kr442.27M

Revenue

kr10.27

Earnings Per Share

88.97%

Gross Margin %

kr113.33M

Free Cash Flow

Revenue

442.27

Earnings Per Share

10.27

Gross Margin %

88.97

Free Cash Flow

113.33

Financials

Year	Year	TTM	2023	2022	2016
Rev.	Revenue	N/A	kr442.27M	kr427.20M	kr0.00M
GM %	Gross Margin %	88.97%	88.97%	89.70%	84.83%
OM	Operating Margin	51.88%	51.88%	47.35%	18.65%
EPS	Earnings Per Share	kr10.27	kr10.27	kr9.16	kr0.67
Div.	Dividends	N/A	kr0.00	kr4.00	kr0.00
PR %	Payout Ratio %	0	0	43.67%	0
Sha.	Shares	N/AM	17.4M	17.4M	15.67M
OCF	Operating Cash Flow	N/A	kr154.15M	kr0.00M	kr0.00M
FCF	Free Cash Flow	N/A	kr113.33M	kr0.00M	kr0.00M
FCFS	Free Cash Flow Per Share	kr6.51	kr6.51	kr6.95	kr-0.80

ChemoMetec A/S financials at a glance

Financials

Discover